Previous close | 39.70 |
Open | 39.02 |
Bid | 38.73 x 70000 |
Ask | 39.32 x 70000 |
Day's range | 39.02 - 39.04 |
52-week range | 35.50 - 59.00 |
Volume | |
Avg. volume | 7 |
Market cap | 1.908B |
Beta (5Y monthly) | 0.85 |
PE ratio (TTM) | 14.41 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Detailed Analysis of Amphastar Pharmaceuticals Inc's Q1 2024 Financial Performance
Amphastar Pharmaceuticals ( NASDAQ:AMPH ) First Quarter 2024 Results Key Financial Results Revenue: US$171.8m (up 23...
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript May 8, 2024 Amphastar Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the Amphastar Pharmaceuticals’ First Quarter Earnings Call. At this time, all participants are […]